Title
Bohol Resort Development, Inc. vs. Doloreich Dumaluan
Case
G.R. No. 261292
Decision Date
Feb 15, 2023
Dispute on reconveyance of land involving nullity of sale and prescription; CA remanded for trial to resolve factual questions; SC affirmed remand, directing RTC to proceed with injunctive relief, pre-trial, and trial.

Case Summary (G.R. No. 261292)

Legal Proceedings and Allegations

The case revolves around a dispute over the ownership of a parcel of land known as Lot 3-B, originally purchased by Doloreich Dumaluan from the heirs of Juan Dumaluan. Doloreich initiated a Complaint on June 6, 2005, for the declaration of the nullity of TCT No. 29414 issued to BRDI and sought reconveyance based on alleged defects in the title stemming from previous transactions involving the land that he claimed included Lot 3-B. Key issues included allegations of fraudulent sales by the Lorejos to Paulino Franco, which Doloreich contended voided subsequent transfers, including those to BRDI.

Regional Trial Court's Decisions

The Regional Trial Court (RTC) initially dismissed the case on October 20, 2015, on the grounds of lack of cause of action, affirmatively determining that BRDI, as a registered owner, was entitled to rely on the title in the absence of contrary evidence. Upon Doloreich's motion for reconsideration, the RTC altered its dismissal grounds to prescription in the order dated March 15, 2016, determining that Doloreich’s claim had already prescribed based on the ten-year limit applicable to actions for reconveyance due to fraud.

Court of Appeals' Reversal

The Court of Appeals (CA) granted Doloreich’s appeal on May 26, 2021, reversing the RTC’s orders and remanding the case for further proceedings. The CA identified Doloreich's complaint as an action for reconveyance based on the void nature of the sale between the Lorejos and Franco, emphasizing that the absence of a full trial to examine the claims deprived the court of sufficient facts to rule on prescription or on the merits.

Key Legal Issues Addressed

The CA articulated that matters regarding the validity of the earlier transactions, potential fraud, and whether Doloreich's action had prescribed required a full exploration of the facts during trial. The court underscored the necessity for a trial to ascertain if the sale was void, which would influence whether the action for reconveyance was imprescriptible—as actions based on fraud are subject to a ten-year prescription from the time of the adverse registration.

Supreme Court's Affirmation

The Supreme Court affirmed the CA's ruling, agreeing that the prescription issue could not be fully resolved without a trial. It clarified that while a case could be dismissed on grounds of prescription, the unique factual circumstances necessitated further factual determinations at trial. The court acknowledged that the nature of the action (i.e., reconveyance) significantly influenced the applicable prescriptive periods, referencing that actions based on the voidness of a sale are imprescriptible.

...continue reading

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster—building context before diving into full texts.